Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-071850
Filing Date
2011-08-03
Accepted
2011-08-03 06:00:50
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c18711e10vq.htm 10-Q 415304
2 EXHIBIT 31.1 c18711exv31w1.htm EX-31.1 8704
3 EXHIBIT 31.2 c18711exv31w2.htm EX-31.2 8735
4 EXHIBIT 32.1 c18711exv32w1.htm EX-32.1 3844
5 EXHIBIT 32.2 c18711exv32w2.htm EX-32.2 3840
  Complete submission text file 0000950123-11-071850.txt   1809905

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT somx-20110630.xml EX-101.INS 213784
7 EX-101 SCHEMA DOCUMENT somx-20110630.xsd EX-101.SCH 9655
8 EX-101 CALCULATION LINKBASE DOCUMENT somx-20110630_cal.xml EX-101.CAL 28273
9 EX-101 LABELS LINKBASE DOCUMENT somx-20110630_lab.xml EX-101.LAB 109960
10 EX-101 PRESENTATION LINKBASE DOCUMENT somx-20110630_pre.xml EX-101.PRE 70610
11 EX-101 DEFINITION LINKBASE DOCUMENT somx-20110630_def.xml EX-101.DEF 10166
Mailing Address 3570 CARMEL MOUNTAIN ROAD SUITE 100 SAN DIEGO CA 92130
Business Address 3570 CARMEL MOUNTAIN ROAD SUITE 100 SAN DIEGO CA 92130 (858) 876-6500
Somaxon Pharmaceuticals, Inc. (Filer) CIK: 0001339455 (see all company filings)

EIN.: 200161599 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51665 | Film No.: 111005179
SIC: 2834 Pharmaceutical Preparations